Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer

The benefit of adjuvant trastuzumab with chemotherapy in breast cancer is well-established; however, its impact on outcomes for older women with small, node-negative, human epidermal growth factor receptor 2-positive disease is less clear and unlikely to be addressed in prospective studies. This ret...

Full description

Saved in:
Bibliographic Details
Published in:Clin Breast Cancer
Main Authors: Cadoo, Karen A., Morris, Patrick G., Cowell, Elizabeth P., Patil, Sujata, Hudis, Clifford A., McArthur, Heather L.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5575753/
https://ncbi.nlm.nih.gov/pubmed/27622751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2016.07.013
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items